Xeljanz®, Xeljanz XR (tofacitinib) – Safety update
February 4, 2021 - The FDA announced that preliminary results from a safety clinical trial show an increased risk of serious heart-related problems and cancer with Xeljanz, Xeljanz XR (tofacitinib) compared to another type of medicine called tumor necrosis factor (TNF) inhibitors.
Top